Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Switch to healthier food and drink choices with UK's first ever 'Foodswitch' App

2014-02-13 FoodswitchLaunching today [13th February] FoodSwitchis the first ever smartphone app that enables UK consumers to make healthier and smarter food and drink choices.  Putting consumers in control whilst out shopping, FoodSwitch

will help customers make more informed decisions when purchasing their weekly shop, in turn reducing their risk of ill health through poor diets.

FoodSwitch allows users to scan the barcode of over 80,000 packaged food and drinks sold across major UK supermarkets using their smartphone camera to receive immediate, easy to understand ‘traffic light’ colour-coded nutritional information along with suggested similar, healthier products. It is now easier than ever for consumers to reduce high levels of fat, salt and sugar in their families’ diet. 

FoodSwitch was developed by leading UK nutrition research experts; Consensus Action on Salt and Health (CASH), the Medical Research Council Human Nutrition Research, The British Heart Foundation Health Promotion Research Group, the Nuffield Department of Population Health and the Nuffield Department of Primary Care Health Sciences, University of Oxford, and led by The George Institute for Global Health (TGI). FoodSwitch is further supported by nine UK organisations. 

Susan Jebb, Professor of Diet and Population Health, Nuffield Department of Primary Care Health Sciences, University of Oxford, who was involved in developing the app, commented: "A poor diet is responsible for tens of thousands of premature deaths every year in the UK.  People will be able to use this smartphone technology to swap the foods in their regular shopping basket for healthier options to help themselves and their families to cut their risk of diabetes, heart disease and some cancers."

Links:
Food Switch website
, Facebook, Twitter

Similar stories

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

AIMday in Women's Health - registration for academics now open

Events Innovation

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.